failure
[용어속성] Term
COVID-19 infections and outcomes in a live registry of heart failure patients across an integrated health care system
Research Article
[키워드] 95% CI
age
blocker
Care
Clinical management
comorbid condition
Connecticut
Coronary artery disease
COVID
COVID-19
COVID-19 infection
COVID-19 testing
death
disease
elderly
failure
Health
heart
heart failure
higher risk
hospital
Hospitalization
hotspot
hypertension
include
increased risk
Infection
large cohort
less
manuscript
Mortality
multiple comorbidity
Older
outcome
Patient
patient mortality
patients
patients died
Prevalence
proportion
registry
Respiratory failure
Result
retrospective
Retrospective analysis
SARS-CoV-2
Spread
Symptomatic patients
tested
was performed
[DOI] 10.1371/journal.pone.0238829 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0238829 PMC 바로가기 [Article Type] Research Article
Association between procalcitonin levels and duration of mechanical ventilation in COVID-19 patients
Research Article
[키워드] 28-day mortality
Adjusted analysis
Admission
assessment
association
average
binary outcome
Cohort
Comorbidities
Comorbidity
comparison
component
COVID-19 patient
COVID-19 patients
demographics
diagnosed with COVID-19
elevated
eligible
failure
Health
help
hospital
identify
initial
intubation
Invasive mechanical ventilation
Laboratory test
Linear regression
Mann-Whitney U test
mechanical ventilation
mechanically ventilated
Multiple linear regression
multivariable
no significant difference
Observational cohort study
outcomes
Patient
Pearson’s chi-square test
plasma
Primary outcome
procalcitonin level
required
resource
Result
risk
secondary outcome
significantly
two groups
Univariate analysis
were assessed
[DOI] 10.1371/journal.pone.0239174 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0239174 PMC 바로가기 [Article Type] Research Article
24 Hours: A Case of Multiorgan Failure Associated With COVID-19
Internal Medicine
[키워드] 24 hour
acidosis
Acute kidney injury
acute respiratory distress
Admission
AKI
ARDS
caused
COVID-19
Cytokine storm
death
died
failure
female
Hemodialysis
Hospital admission
Injury
less
mechanism
Mortality
MOST
progression
renal
renal failure
Risk factors
severe metabolic
syndrome
the disease
the patient
[DOI] 10.7759/cureus.10149 PMC 바로가기 [Article Type] Internal Medicine
[DOI] 10.7759/cureus.10149 PMC 바로가기 [Article Type] Internal Medicine
Disease progression patterns and risk factors associated with mortality in deceased patients with COVID‐19 in Hubei Province, China
Original Research
[키워드] Acute cardiac injury
Acute kidney injury
acute respiratory distress
age
analyzed
assessment
Chest computed tomography
China
collected
Complication
coronavirus disease
COVID‐19
COVID‐19 patient
COVID‐19 patients
COVID‐19
Critical
Day
death
Deceased
description
Deterioration
died
disease course
Disease progression
disease progression pattern
dysfunction
enrolled
Factor
failure
Hospitalization
hospitals
illness onset
independent risk factor
initial
Laboratory
laboratory data
material
Mortality
objective
Patient
patients
preexisting comorbidities
preexisting comorbidity
progression
radiological
Result
risk factor
SARS‐CoV‐2
Sepsis
SOFA
SOFA score
survived
surviving patient
surviving patients
syndrome
variables
[DOI] 10.1002/iid3.343 PMC 바로가기 [Article Type] Original Research
[DOI] 10.1002/iid3.343 PMC 바로가기 [Article Type] Original Research
High dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial
COVID-19에 따른 급성 호흡곤란 증후군에 대한 고용량 덱사메타손 치료: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
active cancer
acute respiratory distress
acute respiratory distress syndrome
Adult patients
advance directives
Advanced cancer
age
alpha error
anticipated
approved
ARDS
assessment
assigned
bilateral pulmonary infiltrates
Blinding
block
breast-feeding
Buenos Aires
capture
cardiac disease
CEMIC
clinical
clinical trial
code
Complete
concealed
Confirmed
COVID-19
COVID-19, Dexamethasone, Acute Respiratory Distress Syndrome, Randomised controlled trial, protocol, Steroids
delirium
develop
Dexamethasone
diagnosis of SARS-CoV-2
directive
discharge
disease
dissemination
do not resuscitate
dose
Effectiveness
element
End-Expiratory Pressure
evaluate
exclusion criteria
Expiratory Pressure
explained
failure
followed by
Frequency
glucocorticoid
Glucocorticoids
group
hemodynamic
High dose
HIV infection
hypoxemic
Hypoxemic respiratory failure
ICU
Immunosuppression
Immunosuppressive agents
include
inclusion criteria
Infection
Informed consent
intensive care unit
International
legal guardian
Length
less
Life expectancy
local Ethics Committee
mechanical ventilation
Mortality
multicenter
muscle weakness
Nosocomial infection
Nosocomial infections
number
objective
open
open label
open trial
other disease
other diseases
outcome
Palliative care
PaO
parallel group
participant
Participation
Patient
Patient care
platform
Pneumonia
Positive end-expiratory pressure
power
power of 80%
Prednisone
pressure
Prone position
protocol
R language
random
randomised
randomised controlled trial
randomization
Randomized
randomized clinical trial
receive
recruitment
Registered
renal
renal disease
respiratory
respiratory distress
Respiratory distress syndrome
Respiratory failure
resuscitate order
RT-PCR
Sample size
SARS-COV-2 infection
SARS-CoV-2 pneumonia
secondary
Secondary outcomes
secondary to
sequence
Sequential Organ Failure Assessment
severe immunosuppression
SOFA
Standard deviation
status
Stratified randomization
Study protocol
subject
Support
syndrome
table
terminal
Terminal disease
title
Treatment
treatment groups
Trial
Trial registration
two-tailed alpha error
Variation
ventilator
ventilator-free day
Ventilator-free days
ventilatory
Version
viral shedding
weakness
website
women
[DOI] 10.1186/s13063-020-04646-y PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04646-y PMC 바로가기 [Article Type] Letter
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia
코로나19 폐렴 환자에서 토실리주맙과 스테로이드 치료
Research Article
[키워드] 95%CI
adjusted
age
analyses
anti-inflammatory treatment
Comorbidities
Comorbidity
controls
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 pneumonia
Cox regression analysis
darunavir
death
defined
determine
difference
early treatment
Efficacy
Endpoint
endpoints
Evidence
failure
group
hazard
hazard ratio
Hospital admission
Hydroxychloroquine
immune response
IMPROVE
intravenously
Intubated
intubation
IQR
lead
male
median
median age
Methylprednisolone
non-intubated patient
non-intubated patients
not intubated
outcome
overall survival
PaO
Patient
patients with COVID-19
Pneumonia
primary endpoint
Propensity score
Ratio
Respiratory failure
Result
Ritonavir
Severe COVID-19 pneumonia
single-center study
Standard of care
steroid
steroid treatment
Steroids
subcutaneously
survival
Tocilizumab
treated patient
Treatment
treatment with tocilizumab
with COVID-19
[DOI] 10.1371/journal.pone.0237831 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0237831 PMC 바로가기 [Article Type] Research Article
COVID-19 with Hypoxic Respiratory Failure
COVID-19 Images in Emergency Medicine
[키워드] characteristic
Chest computed tomography
complications
Computed tomography
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
failure
Ground-glass opacities
ground-glass opacity
hallmark
hypoxic respiratory failure
male
presentation
presenting
progressed
Radiography
respiratory
Shortness of breath
[DOI] 10.5811/cpcem.2020.7.48793 PMC 바로가기 [Article Type] COVID-19 Images in Emergency Medicine
[DOI] 10.5811/cpcem.2020.7.48793 PMC 바로가기 [Article Type] COVID-19 Images in Emergency Medicine
Hydroxychloroquine and Coronavirus Disease 2019: A Systematic Review of a Scientific Failure
Special Issue on the COVID-19 Pandemic
[키워드] administration
adopted
case sery
China
Chloroquine
clinical evidence
clinical study
cohorts
coronavirus
coronavirus disease
Course
COVID-19
death
effort
Europe
Evidence
failure
HCQ
Hydroxychloroquine
mortality rates
no significant effect
non-randomized
observational studies
observational study
pandemic
Prevent
Prophylactic
Prophylaxis
provided
Randomized controlled trial
RCT
RCTs
Result
review
screened
therapeutic
treat
Treatment
Trial
USA
[DOI] 10.5041/RMMJ.10416 PMC 바로가기 [Article Type] Special Issue on the COVID-19 Pandemic
[DOI] 10.5041/RMMJ.10416 PMC 바로가기 [Article Type] Special Issue on the COVID-19 Pandemic